Research Center Unites Biomedical Competitors to Fund Medical Technology Development
Known as the Minimally Invasive Medical Technologies Center (MIMTeC), the collaboration will focus on translational research that enables
The centers initial funding comes from a five-year grant from the National Science Foundations (NSF) Industry/University Cooperative Research Center program and membership fees from a consortium of national biomedical device companies.
Biomedical device companies will commit to at least a three-year, renewable membership in MIMTeC, which entitles them to propose, review and vote on research projects that may benefit the entire group. Device manufacturers are also eligible for affiliate membership in the center, which will allow them to stay up to speed on the emerging technologies they will need to produce future devices.
By collaborating with academia to conduct unbiased research, explains center director Balakrishna Haridas, PhD, industry stakeholders can share the cost of developing new design methodologies and experimental research tools applicable to each companys product development pipeline. MIMTeC is a national resource in that, when the research is complete, all industry partners will have access to the technologies.
Haridas, associate professor of biomedical engineering, spent more than 10 years designing biomedical devices for companies like Medtronic, Boston Scientific and Ethicon Endo-Surgery prior to joining UC.
The center is the result of two years of collaboration between UCs biomedical engineering department and the Center for Surgical Innovation, whose executive director, Chuck Doarn, will serve as administrative director of MIMTeC.
Current members of MIMTeC include Ethicon-Endo Surgery, Procter and Gamble, Boston Scientific, Medtronic, Cordis Corp., the U.S. Army and Greatbatch Inc.
Haridas says he expects the center to fund about six projects a year, split equally between UC and its institutional collaborator, the
Most projects will fall within four broad research themestools and algorithms to measure in vivo properties of tissues and organs; laboratory and computational models of tissues and device interactions that mimic in vivo conditions; instrumentation design for image-guided interventions; and miniature embedded sensors (nanotechnology) used to measure the biophysical properties of device-tissue interactions during surgery.
Were looking at specific design methods and experimental techniques that can be used to test new interventionsfor example, computer-simulated scenarios to predict how human tissue responds to a device made of a specific material, or noninvasive methods to determine the physics of interactions between device and tissue, explains Haridas.
These themes meet the centers goal of developing fundamental enabling technologies that member companies can use to develop minimally invasive interventions.
Its a great model, Haridas adds, because it gives our industry partners access to unbiased research and the university countless opportunities for students to get hands-on training in biomedical research relevant to industry.
At the same time, the underlying model for the center permits timely public disclosure of research in the form of publications and allows students working at the center to disseminate the research results.
Haridas says the benefits to UC go far beyond the increased royalty licenses acquired through the research projects.
Tremendous synergy will be built through this center, he says. And its not just within the biomedical engineering department. Its collaboration between the colleges of engineering and medicine, between industry and academia, between our students and industry.
"MIMTEC builds upon existing partnerships and collaborations, which use UC research core facilities like the Center for Surgical Innovation," adds Doarn. The MIMTEC partnership provides a platform for innovation and discovery, bringing industry, government and academia closer together."
Being an NSF-designated research center also allows UC to apply for much larger grants from the federal government that would allow the university to obtain matching funds from industry for cooperative research projects. Increased research will also provide training opportunities for students as they prepare for careers in the biomedical industry.
The expanded learning opportunities that MIMTeC provides will essentially allow us to mold the next generation of the biomedical engineering workforce, adds Haridas.
Haridas, Doarn and the others currently conducting research projects for MIMTeC have no financial interest in the centers member companies.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.